Literature DB >> 21224040

A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Thomas E Morrison1, Lauren Oko, Stephanie A Montgomery, Alan C Whitmore, Alina R Lotstein, Bronwyn M Gunn, Susan A Elmore, Mark T Heise.   

Abstract

Chikungunya virus (CHIKV), an emerging mosquito-borne Alphavirus, causes debilitating rheumatic disease in humans that can last for weeks to months. Starting in 2004, a CHIKV outbreak in the Indian Ocean region affected millions of people, and infected travelers introduced CHIKV to new regions. The pathogenesis of CHIKV is poorly understood, and no approved vaccines or specific therapies exist. A major challenge to the study of CHIKV disease is the lack of a small animal model that recapitulates the major outcomes of human infection. In this study, the pathogenesis of CHIKV in C57BL/6J mice was investigated using biological and molecular clones of CHIKV isolated from human serum (CHIKV SL15649). After 14-day-old mice were inoculated with CHIKV SL15649 in the footpad, they displayed reduced weight gain and swelling of the inoculated limb. Histologic analysis of hind limb sections revealed severe necrotizing myositis, mixed inflammatory cell arthritis, chronic active tenosynovitis, and multifocal vasculitis. Interestingly, these disease signs and viral RNA persisted in musculoskeletal tissues for at least 3 weeks after inoculation. This work demonstrates the development of a mouse model of CHIKV infection with clinical manifestations and histopathologic findings that are consistent with the disease signs of CHIKV-infected humans, providing a useful tool for studying viral and host factors that drive CHIKV pathogenesis and for evaluating potential therapeutics against this emerging viral disease. Copyright Â
© 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21224040      PMCID: PMC3069999          DOI: 10.1016/j.ajpath.2010.11.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Chikungunya outbreaks--the globalization of vectorborne diseases.

Authors:  Rémi N Charrel; Xavier de Lamballerie; Didier Raoult
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

Review 2.  Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus.

Authors:  Ann M Powers; Christopher H Logue
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

3.  Tenosynovitis and vascular disorders associated with Chikungunya virus-related rheumatism.

Authors:  Philippe Parola; Fabrice Simon; Manuela Oliver
Journal:  Clin Infect Dis       Date:  2007-09-15       Impact factor: 9.079

4.  Europe witnesses first local transmission of chikungunya fever in Italy.

Authors:  Rory Watson
Journal:  BMJ       Date:  2007-09-15

5.  Retrospective survey of Chikungunya disease in Réunion Island hospital staff.

Authors:  F Staikowsky; K Le Roux; I Schuffenecker; P Laurent; P Grivard; A Develay; A Michault
Journal:  Epidemiol Infect       Date:  2007-04-16       Impact factor: 2.451

6.  Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease.

Authors:  Thomas E Morrison; Robert J Fraser; Paul N Smith; Suresh Mahalingam; Mark T Heise
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

7.  Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus.

Authors:  Philippe Laurent; Karin Le Roux; Philippe Grivard; Gérard Bertil; Florence Naze; Miguel Picard; Frédérik Staikowsky; Georges Barau; Isabelle Schuffenecker; Alain Michault
Journal:  Clin Chem       Date:  2007-06-22       Impact factor: 8.327

8.  Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases.

Authors:  Fabrice Simon; Philippe Parola; Marc Grandadam; Sabrina Fourcade; Manuela Oliver; Philippe Brouqui; Pierre Hance; Philippe Kraemer; Anzime Ali Mohamed; Xavier de Lamballerie; Rémi Charrel; Hugues Tolou
Journal:  Medicine (Baltimore)       Date:  2007-05       Impact factor: 1.889

9.  Novel chikungunya virus variant in travelers returning from Indian Ocean islands.

Authors:  Philippe Parola; Xavier de Lamballerie; Jacques Jourdan; Clarisse Rovery; Véronique Vaillant; Philippe Minodier; Philippe Brouqui; Antoine Flahault; Didier Raoult; Rémi N Charrel
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

10.  Human muscle satellite cells as targets of Chikungunya virus infection.

Authors:  Simona Ozden; Michel Huerre; Jean-Pierre Riviere; Lark L Coffey; Philippe V Afonso; Vincent Mouly; Jean de Monredon; Jean-Christophe Roger; Mohamed El Amrani; Jean-Luc Yvin; Marie-Christine Jaffar; Marie-Pascale Frenkiel; Marion Sourisseau; Olivier Schwartz; Gillian Butler-Browne; Philippe Desprès; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  PLoS One       Date:  2007-06-13       Impact factor: 3.240

View more
  129 in total

1.  Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.

Authors:  Christina L Gardner; Crystal W Burke; Stephen T Higgs; William B Klimstra; Kate D Ryman
Journal:  Virology       Date:  2012-02-01       Impact factor: 3.616

2.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

3.  Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis.

Authors:  Jonathan J Miner; Lindsey E Cook; Jun P Hong; Amber M Smith; Justin M Richner; Raeann M Shimak; Alissa R Young; Kristen Monte; Subhajit Poddar; James E Crowe; Deborah J Lenschow; Michael S Diamond
Journal:  Sci Transl Med       Date:  2017-02-01       Impact factor: 17.956

4.  Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.

Authors:  Lindsey E Cook; Marissa C Locke; Alissa R Young; Kristen Monte; Matthew L Hedberg; Raeann M Shimak; Kathleen C F Sheehan; Deborah J Veis; Michael S Diamond; Deborah J Lenschow
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

5.  The growth of arthralgic Ross River virus is restricted in human monocytic cells.

Authors:  Pascale Krejbich-Trotot; Essia Belarbi; Miora Ralambondrainy; Chaker El-Kalamouni; Wildriss Viranaicken; Pierre Roques; Philippe Desprès; Gilles Gadea
Journal:  Virus Res       Date:  2016-09-13       Impact factor: 3.303

6.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

7.  The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.

Authors:  Emma S Winkler; Swathi Shrihari; Barry L Hykes; Scott A Handley; Prabhakar S Andhey; Yan-Jang S Huang; Amanda Swain; Lindsay Droit; Kranthi K Chebrolu; Matthias Mack; Dana L Vanlandingham; Larissa B Thackray; Marina Cella; Marco Colonna; Maxim N Artyomov; Thaddeus S Stappenbeck; Michael S Diamond
Journal:  Cell       Date:  2020-07-14       Impact factor: 41.582

8.  CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Authors:  Kristina S Burrack; Stephanie A Montgomery; Dirk Homann; Thomas E Morrison
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

9.  γδ T Cells Play a Protective Role in Chikungunya Virus-Induced Disease.

Authors:  Kristin M Long; Martin T Ferris; Alan C Whitmore; Stephanie A Montgomery; Lance R Thurlow; Charles E McGee; Carlos A Rodriguez; Jean K Lim; Mark T Heise
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

10.  Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice.

Authors:  Kristin M Long; Alan C Whitmore; Martin T Ferris; Gregory D Sempowski; Charles McGee; Bianca Trollinger; Bronwyn Gunn; Mark T Heise
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.